Even with rising PSA on hormone therapy*

NUBEQA HELPS YOU LIVE FOR WHAT YOU LOVE

NUBEQA® (darolutamide) is a prescription medicine used to treat men with prostate cancer that has not spread to other parts of the body and no longer responds to a medical or surgical treatment that lowers testosterone.

It is not known if NUBEQA is safe and effective in women and children.

Alt tag

NUBEQA CAN HELP

If hormone therapy* no longer controls your prostate cancer that has not spread to other parts of the body

AND

Your PSA is still rising and your testosterone levels are low

*Hormone therapy includes gonadotropin-releasing hormone (GnRH), such as Lupron Depot® (drug treatment), or surgery that lowers testosterone.

LEARN FROM THIS RESOURCE

Find out what NUBEQA can offer you, and get resources and support to help you along the way.

Download Patient Brochure
Download the NUBEQA Patient Brochure

NUBEQA FREE TRIAL PROGRAM

Patients who are NEW to NUBEQA can get 1 month of free medication.†

1

MONTH FREE

Find out how

ASK YOUR DOCTOR IF NUBEQA IS RIGHT FOR YOU

Pronounced (new-BEH-kah)

†The NUBEQA Free Trial Program provides 1 month's supply of NUBEQA at no cost to patients who meet the program eligibility requirements and agree to the terms and conditions. For full terms and conditions, please call Access Services by BayerTM at 1-800-288-8374.

Lupron Depot is a registered trademark of AbbVie Inc.

PSA=prostate-specific antigen.

Man Running

STAY IN THE KNOW

If you would like to receive tools, tips, and NUBEQA information and support, sign up to receive future updates.

WHY NUBEQA?

NUBEQA has clinically proven effectiveness and tolerability. It can help delay the spread of prostate cancer to other parts of the body when you are no longer responding to a medical or surgical treatment that lowers testosterone.

Learn what NUBEQA can do
More information Less information

INDICATION

NUBEQA® (darolutamide) is a prescription medicine used to treat men with prostate cancer that has not spread to other parts of the body and no longer responds to a medical or surgical treatment that lowers testosterone.

It is not known if NUBEQA is safe and effective in women and children.

IMPORTANT SAFETY INFORMATION

NUBEQA can harm unborn babies and cause loss of pregnancy. Men with female partners who may become pregnant should use effective birth control (contraception) during treatment and for 1 week after the last dose of NUBEQA.

Before taking NUBEQA, tell your healthcare provider about all your medical conditions, including if you:

  • Have kidney or liver problems.
  • Have a partner who may become pregnant. Males who have female partners who may become pregnant should use effective birth control (contraception) during treatment and for 1 week after the last dose of NUBEQA. Talk with your healthcare provider about birth control methods.
  • For women, tell your healthcare provider if you are:
    • pregnant or plan to become pregnant. NUBEQA can cause harm to your unborn baby and loss of pregnancy (miscarriage)
    • breastfeeding or plan to breastfeed. It is not known if NUBEQA passes into breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. NUBEQA may affect the way other medicines work and other medicines may affect how NUBEQA works.

You should not start or stop any medicine without talking to your healthcare provider.

Most common side effects of NUBEQA include:

  • Feeling more tired than usual
  • Arm, leg, hand, or foot pain
  • Rash
  • Decreased white blood cells (neutropenia)
  • Changes in tests that determine how your liver works (liver function tests)

NUBEQA may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility.

These are not all the possible side effects of NUBEQA. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 1-800-FDA-1088 or www.fda.gov/medwatch.

For important risk and use information about NUBEQA, please see the full Prescribing Information.

© 2022 Bayer. All rights reserved. BAYER, the Bayer Cross and NUBEQA are registered trademarks of Bayer, and Access Services by Bayer is a trademark of Bayer.

Date of last update: 02/04/2022